Autoantibodies to IA-2 in insulin-dependent diabetes mellitus

Sepe, 1997, Islet-related autoantigens and the pathogenesis of insulin-dependent diabetes mellitus. A 1996 update, 22, 68

Winter, 1996, The immunoendocrinopathies. Part 1: overview and insulin-dependent diabetes mellitus, Diagn Endocrinol Metab Am Assoc Clin Chem, 14, 13

Christie, 1996, Islet cell autoantigens in type 1 diabetes, Eur J Clin Invest, 26, 827, 10.1111/j.1365-2362.1996.tb02126.x

Rabin, 1992, Cloning and expression of IDDM-specific human autoantigens, Diabetes, 41, 183, 10.2337/diabetes.41.2.183

Christie, 1993, Detection of pancreatic islet 64,000 Mr autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase, J Clin Invest, 92, 240, 10.1172/JCI116556

Rabin, 1994, Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases, J Immunol, 152, 3183, 10.4049/jimmunol.152.6.3183

Payton, 1995, Relationship of the 37 000- and 40 000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512), J Clin Invest, 96, 1506, 10.1172/JCI118188

Lan, 1996, IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus, Proc Natl Acad Sci USA, 93, 6367, 10.1073/pnas.93.13.6367

Lan, 1994, Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma, DNA Cell Biol, 13, 505, 10.1089/dna.1994.13.505

Lampasone, 1996, Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen, J Immunol, 157, 2707, 10.4049/jimmunol.157.6.2707

Bonifacio, 1995, Identification of protein tyrosine phosphatase-like IA2 (Islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies, J Immunol, 155, 5419, 10.4049/jimmunol.155.11.5419

Notkins, 1996, IA-2 and IA-2β are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments, J Autoimmunity, 9, 677, 10.1006/jaut.1996.0088

Gorus, 1997, Belgian Diabetes Registry. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings, Diabetologia, 40, 95, 10.1007/s001250050648

Beever, 1989, Highly sensitive assays of autoantibodies to thyroglobulin and thyroid peroxidase, Clin Chem, 35, 1949, 10.1093/clinchem/35.9.1949

Southgate, 1984, A receptor assay for the measurement of TSH receptor antibodies in unextracted serum, Clin Endocrinol, 20, 539, 10.1111/j.1365-2265.1984.tb00102.x

1985

Smith, 1994, Expression and purification of glutathione-S-transferase fusion proteins, Curr Protoc Mol Biol, 2, 16:7:1

Greenwood, 1963, The preparation of 131I-labelled human growth hormone of high specific radioactivity, Biochem J, 89, 114, 10.1042/bj0890114

Colls, 1995, Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases, Clin Chem, 41, 375, 10.1093/clinchem/41.3.375

Powell, 1996, Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast, Clin Chim Acta, 256, 175, 10.1016/S0009-8981(96)06422-4

Williams, 1997, A novel micro-assay for insulin autoantibodies, J Autoimmunity, 10, 473, 10.1006/jaut.1997.0154

Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0

Bland, 1986, Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 8, 307, 10.1016/S0140-6736(86)90837-8

Morgenthaler, 1998, Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in type-1 diabetes, Horm Metab Res, 30, 559, 10.1055/s-2007-978933

Xie, 1998, Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2 in Sf-9 cells, Clin Exp Immunol, 113, 367, 10.1046/j.1365-2249.1998.00676.x

Petersen, 1994, Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay, Diabetes, 43, 459, 10.2337/diabetes.43.3.459

Grubin, 1994, A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM, Diabetologia, 37, 344, 10.1007/BF00408469

Gianani, 1995, ICA512 autoantibody radioassay, Diabetes, 44, 1340, 10.2337/diabetes.44.11.1340

Morgenthaler, 1997, Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome, Autoimmunity, 25, 203, 10.3109/08916939708994729

Seissler, 1998, Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease, Diabetologia, 41, 891, 10.1007/s001250051004

Hawa, 1997, Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes, Diabetes, 46, 1270, 10.2337/diabetes.46.8.1270

Feeney, 1997, Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM, Diabetes Care, 20, 1403, 10.2337/diacare.20.9.1403

Kasuga, 1997, Autoantibody against IA-2 improves the test sensitivity for insulin-dependent diabetes mellitus in Japanese patients of child onset, Endocr J, 44, 485, 10.1507/endocrj.44.485

Bingley, 1997, Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers, Diabetes, 46, 1701, 10.2337/diabetes.46.11.1701

Pastore, 1998, Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives, Diabetes Care, 21, 1445, 10.2337/diacare.21.9.1445

Dittler, 1998, GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives, Diabetes, 47, 592, 10.2337/diabetes.47.4.592

Verge, 1996, Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies, Diabetes, 45, 926, 10.2337/diabetes.45.7.926

Wiest-Ladenburger, 1997, Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test, Diabetes, 46, 565, 10.2337/diabetes.46.4.565

Turner, 1997, UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes, Lancet, 350, 1288, 10.1016/S0140-6736(97)03062-6

Inukai, 1997, Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase, Exp Clin Endocrinol Diabetes, 105, 327, 10.1055/s-0029-1211773